DGX - Quest Diagnostics elects CEO Davis as chairman
- Quest Diagnostics ( NYSE: DGX ) said Friday its board elected CEO James Davis to serve in the additional role of chairman , effective April 1.
- Davis will succeed former CEO Steve Rusckowski, who will remain as chairman through March 31.
- Davis serves as CEO and president, a role he assumed in November 2022 after a gradual leadership transition plan.
- Earlier, Quest( DGX ) and Tower Health teamed up to provide laboratory services .
For further details see:
Quest Diagnostics elects CEO Davis as chairman